genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Drug research and development

Qubit Number to Simulate Molecules Reportedly Reduced by the Sorbonne and Qubit Pharmaceuticals
Artificial Intelligence

Qubit Number to Simulate Molecules Reportedly Reduced by the Sorbonne and Qubit Pharmaceuticals

GLP1 and Harmine Therapy Reverses Diabetes in Mice by Regenerating Beta Cells
Insights

GLP1 and Harmine Therapy Reverses Diabetes in Mice by Regenerating Beta Cells

Nirrin Launches Atlas for At-Line Analysis at the Point of Sampling
Bioprocessing

Nirrin Launches Atlas for At-Line Analysis at the Point of Sampling

Biosimilar Manufacturer Focuses on Process Optimization
Bioprocessing

Biosimilar Manufacturer Focuses on Process Optimization

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs
Drug Discovery

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic
Artificial Intelligence

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic

Navigating the Organ-on-Chip Landscape: Latest Regulatory Insights and the Path to Widespread Adoption
Multimedia

Navigating the Organ-on-Chip Landscape: Latest Regulatory Insights and the Path to Widespread Adoption

Weight-Loss Drugs Could Exploit Fat Cells’ White-to-Beige Mechanism
Drug Discovery

Weight-Loss Drugs Could Exploit Fat Cells’ White-to-Beige Mechanism

Creating Consistency and Confidence for Biopharma Companies
Bioprocessing

Creating Consistency and Confidence for Biopharma Companies

Overcoming Drug-Resistant Acute Myeloid Leukemia with Engineered Compound
Cancer

Overcoming Drug-Resistant Acute Myeloid Leukemia with Engineered Compound

123...896Page 1 of 896

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up